Quote:

---

Of course in order for the intellectual property to be sustained, it would have to be something that is unique and not be merely the obvious and natural implication of Cytodyn,s intellectual property.

---

Not being medically trained and proposing leronlimab for pulmonary inflammation in cases of extreme influenza (same MOA as Covid) weeks before Cytodyn mentioned leronlimab for Covid I would say it's use in Covid was pretty obvious.